119 related articles for article (PubMed ID: 18653245)
1. A relative weak leg muscle in the rolling Nagoya mouse as a model for Lambert-Eaton myasthenic syndrome.
Molenaar PC
J Neuroimmunol; 2008 Sep; 201-202():166-71. PubMed ID: 18653245
[TBL] [Abstract][Full Text] [Related]
2. Severely impaired neuromuscular synaptic transmission causes muscle weakness in the Cacna1a-mutant mouse rolling Nagoya.
Kaja S; van de Ven RC; van Dijk JG; Verschuuren JJ; Arahata K; Frants RR; Ferrari MD; van den Maagdenberg AM; Plomp JJ
Eur J Neurosci; 2007 Apr; 25(7):2009-20. PubMed ID: 17439489
[TBL] [Abstract][Full Text] [Related]
3. Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.
Takamori M
J Neuroimmunol; 2008 Sep; 201-202():145-52. PubMed ID: 18653248
[TBL] [Abstract][Full Text] [Related]
4. Type 2 fiber predominance in Lambert-Eaton myasthenic syndrome.
Squier M; Chalk C; Hilton-Jones D; Mills KR; Newsom-Davis J
Muscle Nerve; 1991 Jul; 14(7):625-32. PubMed ID: 1922168
[TBL] [Abstract][Full Text] [Related]
5. Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse.
Waterman SA; Lang B; Newsom-Davis J
Ann Neurol; 1997 Aug; 42(2):147-56. PubMed ID: 9266723
[TBL] [Abstract][Full Text] [Related]
6. Stimulated single-fiber electromyography in Lambert-Eaton myasthenic syndrome.
Chaudhry V; Watson DF; Bird SJ; Cornblath DR
Muscle Nerve; 1991 Dec; 14(12):1227-30. PubMed ID: 1662773
[TBL] [Abstract][Full Text] [Related]
7. Calcium channel subtypes contributing to acetylcholine release from normal, 4-aminopyridine-treated and myasthenic syndrome auto-antibodies-affected neuromuscular junctions.
Giovannini F; Sher E; Webster R; Boot J; Lang B
Br J Pharmacol; 2002 Aug; 136(8):1135-45. PubMed ID: 12163346
[TBL] [Abstract][Full Text] [Related]
8. Passive transfer of Lambert-Eaton syndrome to mice induces dihydropyridine sensitivity of neuromuscular transmission.
Flink MT; Atchison WD
J Physiol; 2002 Sep; 543(Pt 2):567-76. PubMed ID: 12205190
[TBL] [Abstract][Full Text] [Related]
9. Lambert-Eaton myasthenic syndrome in childhood.
Kostera-Pruszczyk A; Ryniewicz B; Rowinska-Marcinska K; Dutkiewicz M; Kamińska A
Eur J Paediatr Neurol; 2009 Mar; 13(2):194-6. PubMed ID: 18585938
[TBL] [Abstract][Full Text] [Related]
10. Lambert-Eaton myasthenic syndrome: mouse passive-transfer model illuminates disease pathology and facilitates testing therapeutic leads.
Meriney SD; Tarr TB; Ojala KS; Wu M; Li Y; Lacomis D; Garcia-Ocaña A; Liang M; Valdomir G; Wipf P
Ann N Y Acad Sci; 2018 Jan; 1412(1):73-81. PubMed ID: 29125190
[TBL] [Abstract][Full Text] [Related]
11. Lambert-Eaton myasthenic syndrome.
Mareska M; Gutmann L
Semin Neurol; 2004 Jun; 24(2):149-53. PubMed ID: 15257511
[TBL] [Abstract][Full Text] [Related]
12. Lambert-Eaton myasthenic syndrome in children.
Tsao CY; Mendell JR; Friemer ML; Kissel JT
J Child Neurol; 2002 Jan; 17(1):74-6. PubMed ID: 11913581
[TBL] [Abstract][Full Text] [Related]
13. Monozygous twins with neuromuscular transmission defects at opposite sides of the motor endplate.
Punga AR; Nygren I; Askmark H; Stålberg EV
Acta Neurol Scand; 2009 Mar; 119(3):207-11. PubMed ID: 18684214
[TBL] [Abstract][Full Text] [Related]
14. Repetitive nerve stimulation studies in the Lambert-Eaton myasthenic syndrome.
Tim RW; Sanders DB
Muscle Nerve; 1994 Sep; 17(9):995-1001. PubMed ID: 8065402
[TBL] [Abstract][Full Text] [Related]
15. Lambert-Eaton myasthenic syndrome as an autoimmune calcium channelopathy.
Takamori M
Biochem Biophys Res Commun; 2004 Oct; 322(4):1347-51. PubMed ID: 15336982
[TBL] [Abstract][Full Text] [Related]
16. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
Andreis I; Lovnićki TJ; Beara N; Taradi M
Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
[TBL] [Abstract][Full Text] [Related]
17. Synaptotagmin can cause an immune-mediated model of Lambert-Eaton myasthenic syndrome in rats.
Takamori M; Hamada T; Komai K; Takahashi M; Yoshida A
Ann Neurol; 1994 Jan; 35(1):74-80. PubMed ID: 8285596
[TBL] [Abstract][Full Text] [Related]
18. Simulations of active zone structure and function at mammalian NMJs predict that loss of calcium channels alone is not sufficient to replicate LEMS effects.
Ginebaugh SP; Badawi Y; Laghaei R; Mersky G; Wallace CJ; Tarr TB; Kaufhold C; Reddel S; Meriney SD
J Neurophysiol; 2023 May; 129(5):1259-1277. PubMed ID: 37073966
[TBL] [Abstract][Full Text] [Related]
19. Gene dosage-dependent transmitter release changes at neuromuscular synapses of CACNA1A R192Q knockin mice are non-progressive and do not lead to morphological changes or muscle weakness.
Kaja S; van de Ven RC; Broos LA; Veldman H; van Dijk JG; Verschuuren JJ; Frants RR; Ferrari MD; van den Maagdenberg AM; Plomp JJ
Neuroscience; 2005; 135(1):81-95. PubMed ID: 16111830
[TBL] [Abstract][Full Text] [Related]
20. Lambert-eaton myasthenic syndrome differential reactivity of tumor versus non-tumor patients to subunits of the voltage-gated calcium channel.
Pellkofer HL; Armbruster L; Krumbholz M; Titulaer MJ; Verschuuren JJ; Schumm F; Voltz R
J Neuroimmunol; 2008 Nov; 204(1-2):136-9. PubMed ID: 18809213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
